| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43380-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73398 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73148 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43126-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43239-0.05mg | |||
![Flow Cytometry: CD90.2 Antibody (53-2.1) [NBP1-43380] - Analysis using the FITC conjugate of NBP1-43380. Staining of mouse splenocytes with Anti-Mouse CD90.2 (Thy-1.2) FITC (left ) or PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/CD90-2-Antibody-53-2-1-Flow-Cytometry-NBP1-43380-img0003.jpg "Flow Cytometry: CD90.2 Antibody (53-2.1) [NBP1-43380] - Analysis using the FITC conjugate of NBP1-43380. Staining of mouse splenocytes with Anti-Mouse CD90.2 (Thy-1.2) FITC (left ) or PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.")
![Western Blot: PIAS2 Antibody (2B5) [NBP2-46394] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PIAS2.](http://images.novusbio.com/fullsize/PIAS2-Antibody-2B5-Western-Blot-NBP2-46394-img0001.jpg "Western Blot: PIAS2 Antibody (2B5) [NBP2-46394] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PIAS2.")
![Western Blot: Orai2 Antibody (8D11) [NBP2-46295] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ORAI2.](http://images.novusbio.com/fullsize/Orai2-Antibody-8D11-Western-Blot-NBP2-46295-img0001.jpg "Western Blot: Orai2 Antibody (8D11) [NBP2-46295] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ORAI2.")
![SDS-Page: Recombinant Human S100A9 Protein [NBP1-44500] - 3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain](http://images.novusbio.com/fullsize/Recombinant-Human-S100A9-Protein-SDS-Page-NBP1-44500-img0002.jpg "SDS-Page: Recombinant Human S100A9 Protein [NBP1-44500] - 3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain")
![Flow Cytometry: ICOS Antibody (ISA-3) [NBP1-43126] - Staining of CD3 + CD28 stimulated human PBMC with Anti-Human CD278 (ICOS) FITC (left), and Anti-Human CD278 (ICOS) PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis](http://images.novusbio.com/fullsize/ICOS-Antibody-ISA-3-Flow-Cytometry-NBP1-43126-img0001.jpg "Flow Cytometry: ICOS Antibody (ISA-3) [NBP1-43126] - Staining of CD3 + CD28 stimulated human PBMC with Anti-Human CD278 (ICOS) FITC (left), and Anti-Human CD278 (ICOS) PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis")
![Flow Cytometry: IL-13 Antibody (13A) [NBP1-43239] - Analysis using PE conjugate of NBP1-43239. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (cat. 16-0031), soluble Anti-Mouse CD28 Functional Grade Purified (cat. 16-0281), Mouse IL-2 Recombinant Protein (cat. 14-8021), and Mouse IL-4 Recombinant Protein (cat. 14-8041). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized then stained with Anti-Mouse CD4 FITC (cat. 11-0042) and 0.125 ug of Rat IgG1 K Isotype Control PE (cat. 12-4301) or 0.125 ug of Anti-Mouse IL-13 PE. Viable cells, as determined by Fixable Viability Dye eFluor® 780, were used for analysis.](http://images.novusbio.com/fullsize/IL-13-Antibody-13A-Flow-Cytometry-NBP1-43239-img0001.jpg "Flow Cytometry: IL-13 Antibody (13A) [NBP1-43239] - Analysis using PE conjugate of NBP1-43239. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (cat. 16-0031), soluble Anti-Mouse CD28 Functional Grade Purified (cat. 16-0281), Mouse IL-2 Recombinant Protein (cat. 14-8021), and Mouse IL-4 Recombinant Protein (cat. 14-8041). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized then stained with Anti-Mouse CD4 FITC (cat. 11-0042) and 0.125 ug of Rat IgG1 K Isotype Control PE (cat. 12-4301) or 0.125 ug of Anti-Mouse IL-13 PE. Viable cells, as determined by Fixable Viability Dye eFluor® 780, were used for analysis.")
![ELISA: Human IgG ELISA Kit (Colorimetric) [NBP2-60474] - Standard curve.](http://images.novusbio.com/fullsize/Human-IgG-ELISA-Kit-Colorimetric-ELISA-NBP2-60474-img0001.jpg "ELISA: Human IgG ELISA Kit (Colorimetric) [NBP2-60474] - Standard curve.")
![Western Blot: HLA F Antibody [NBP1-59524] - HepG2 cell lysate, concentration 0.2-1 ug/ml.](http://images.novusbio.com/fullsize/HLA-F-Antibody-Western-Blot-NBP1-59524-img0002.jpg "Western Blot: HLA F Antibody [NBP1-59524] - HepG2 cell lysate, concentration 0.2-1 ug/ml.")
![Western Blot: HLA F Antibody [NBP1-59524] - Human Fetal Lung, Antibody Dilution: 1.0 ug/ml.](http://images.novusbio.com/fullsize/HLA-F-Antibody-Western-Blot-NBP1-59524-img0003.jpg)
![Western Blot: IA-2/PTPRN Antibody [NBP1-59411] - HepG2 cell lysate, concentration 0.0625ug/ml.](http://images.novusbio.com/fullsize/IA-2-PTPRN-Antibody-Western-Blot-NBP1-59411-img0002.jpg "Western Blot: IA-2/PTPRN Antibody [NBP1-59411] - HepG2 cell lysate, concentration 0.0625ug/ml.")
![Western Blot: IA-2/PTPRN Antibody [NBP1-59411] - Human Kidney, Antibody Dilution: 0.5 ug/ml.](http://images.novusbio.com/fullsize/IA-2-PTPRN-Antibody-Western-Blot-NBP1-59411-img0003.jpg)
![Western Blot: proBNP Antibody (5B6) [NB120-13111] - Detection of human recombinant NT-proBNP expressed in E. coli in Western blotting by different monoclonal antibodies after Tricine- SDS gel electrophoresis. Lanes: 1 - MAb 5B61-12; 2 - 15F1113-24; 3 - 11D131-39; 4 - 15D748-56; 5 -24E1167-76. Antigen: recombinant NT-proBNP expressed in E. coli, 2.5 ug/well.](http://images.novusbio.com/fullsize/proBNP-Antibody-5B6-Western-Blot-NB120-13111-img0008.jpg "Western Blot: proBNP Antibody (5B6) [NB120-13111] - Detection of human recombinant NT-proBNP expressed in E. coli in Western blotting by different monoclonal antibodies after Tricine- SDS gel electrophoresis. Lanes: 1 - MAb 5B61-12; 2 - 15F1113-24; 3 - 11D131-39; 4 - 15D748-56; 5 -24E1167-76. Antigen: recombinant NT-proBNP expressed in E. coli, 2.5 ug/well.")
![Western Blot: proBNP Antibody (5B6) [NB120-13111] - Tricine-SDS-PAGE in reducing conditions of recombinant NT-proBNP and proBNP expressed in E. coli. Lane 1: low molecular weight standards (Bio-Rad) Lane 2: proBNP, 3 ug Lane 3: NT-proBNP, 3 ug Gel staining: Coomassie brilliant blue R-250](http://images.novusbio.com/fullsize/proBNP-Antibody-5B6-Western-Blot-NB120-13111-img0003.jpg)